Test Results What the results mean Vaccination recommended? HBsAg anti-HBc anti-HBs: negative negative negative: may become infected: vaccinate as indicated based on risk factors for developing ...

SAN DIEGO — Treatment with combination tobevibart and elebsiran led to hepatitis B surface antigen loss among 39% of patients with chronic HBV and low baseline HBsAg, which rose to 46% by adding ...

If this HBsAg-positive, HBeAg-negative patient's HBV DNA titer is currently ≥ 100,000 copies per mL in the presence of normal aminotransferases, the patient should undergo liver biopsy.

Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

Lower HBsAG level at end of treatment was associated with lower relapse rate and higher rate of HBsAG lows,” Yen-Chun Liu, MD, of the Chang Gung University College of Medicine, said during the ...

If either HBsAg or anti-HBc is positive, the patient should be tested for the presence of viral DNA. Conclusions The updated guidelines prescribe best practices for the management of HBVr based on ...

One patient in the treatment arm achieved undetectable HBsAg and another had a >1.5 log 10 decline between the last two visits during the NA-therapy discontinuation follow-up period.

Although HBsAg can be produced from integrated HBV DNA, it is important to note that integrated HBV sequences cannot provide a template for productive viral replication because the complete genome ...